Europe — EMA
Olanzapin Accord (Olanzapine)
Olanzapine, the active ingredient in Olanzapin Accord, is a atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and bipolar disorder in adults.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapin Accord, is a atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and bipolar disorder in adults.
GNH USA supplies Olanzapin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapin Accord is an atypical antipsychotic that modulates neurotransmitter activity in psychotic and mood disorders. - Schizophrenia: Improves positive and negative symptoms and reduces relapse risk. - Bipolar I disorder: Helps control manic episodes and maintenance therapy. - Schizoaffective disorder: Alleviates psychotic features and mood instability. - Psychotic depression: Enhances response to antidepressant therapy.
What are the side effects of Olanzapine?
Common Side Effects: - Weight gain: Increased appetite and caloric intake. - Sedation: Drowsiness or feeling of tired tired t t t. - Dry mouth: Reduced salivation. - Constipation: Slowed gastrointestinal motility. - Elevated triglycerides: Changes in lipid metabolism. - Orthostatic hypotension: Light‑headed g g ight ight ight
Serious or Rare Side Effects: - Neuro‑trophic ewline - ewline -
